The latest articles, editorials and news releases from InvestorBrandNetwork (IBN), a growing Investor Brand Platform.
RSS Feed for InvestorBrandNetwork (IBN)April 13, 2026 — Low-dose THC drinks may be gaining shelf space in bars and retail chains, but they are not resonating with marijuana shoppers in California, according to industry representatives. As lawmakers weigh the proposed restrictions, the debate underscores broader questions about how cannabis products are regulated and who they are intended to serve.
April 13, 2026 — Beyond Meat (NASDAQ: BYND) has fallen from a peak valuation of more than $14 billion to penny stock territory, driven by a combination of declining sales, mounting losses, intensifying competition and eroding consumer demand, according to a MarketWatch report by Bill Peters and Tomi Kilgore. Once buoyed by IPO enthusiasm and expectations of mass adoption, the company now faces a shrinking addressable market, widening price gaps with traditional meat and continued cash burn, with revenue falling 20% and operational losses more than tripling in recent results.
April 13, 2026 — This article has been disseminated on behalf of Lahontan Gold Corp. and may include paid advertising.
April 13, 2026 — Safe Pro Group, a developer of security and defense solutions, has appointed decorated SOCOM Joint Acquisition Task Force Commander Jarret Mathews as Chief Operating Officer. Mathews brings more than 25 years of experience to the table, with expertise in operational leadership, defense acquisition, and advanced technology integration.
April 13, 2026 — Disseminated on behalf of LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF)and may include paid advertising.
April 13, 2026 — Xeriant (OTCQB: XERI), a company focused on developing and commercializing advanced technologies, announced the completion of a critical phase of internal testing for its NEXBOARD(TM) composite building panel, demonstrating strong fire-resistant performance ahead of third-party certification. The company is preparing for formal NFPA 286 and ASTM E84 testing, following internal trials showing no combustion or smoke under extreme heat, while refining manufacturing processes to support scalable production as it moves toward commercialization and broader adoption in residential and commercial construction.
April 13, 2026 — Datavault AI (NASDAQ: DVLT), a provider of data monetization, credentialing, digital engagement and real-world asset tokenization technologies, announced plans to list its proprietary meme coin portfolio and RWA token suite on the Biconomy exchange, targeting expanded liquidity and distribution across Southeast Asian and global markets. The listings will include Dream Bowl and Josh Gibson-themed digital assets alongside RWA stablecoins, building on the company’s existing TRITON token already trading on Biconomy, as Datavault advances its tokenization pipeline and broader Information Data Exchange strategy while leveraging the platform’s global user base and trading volume to drive adoption visibility for emerging football talent through a broad sports and entertainment audience.
April 13, 2026 — Greenland Energy (NASDAQ: GLND) announced its placement in an editorial published by NetworkNewsWire, highlighting how rising geopolitical tensions and disruptions to critical shipping routes such as the Strait of Hormuz are underscoring ongoing vulnerabilities in global energy security. The editorial emphasizes growing investor focus on companies advancing resource development in politically stable regions, positioning Greenland Energy as a key player through its exploration efforts in the Jameson Land Basin as part of broader efforts to strengthen Western energy independence.
April 13, 2026 — LIXTE Biotechnology Holdings (NASDAQ: LIXT), a clinical-stage pharmaceutical company advancing cancer treatments, announced preliminary results from a clinical trial evaluating its proprietary compound LB-100 in combination with dostarlimab at the 2026 Society of Gynecologic Oncology conference in San Juan, Puerto Rico. Interim data from 20 evaluable patients showed a 40% disease control rate and encouraging survival trends with an acceptable safety profile, supporting continued enrollment of an expanded cohort as the company investigates the combination’s potential to enhance immunotherapy response in ovarian clear cell carcinoma.
April 13, 2026 — The rise of artificial intelligence has sparked fear and uncertainty about the future of work, especially for people just starting their careers. Many believed that entry-level jobs would disappear as machines took over basic tasks.
April 13, 2026 — Stanford University scientists developed a molecular urine analysis that can distinguish bladder cancer patients who need immunotherapy from those already cured by surgical removal, transforming treatment planning for roughly 60,000 Americans diagnosed yearly with early-stage disease. As many more companies like Calidi Biotherapeutics Inc.
April 13, 2026 — As supply deficits continue to influence platinum markets, the precious metal has registered a 30% climb in its price so far this year. This is according to a report on commodity prices published in April by the World Bank.
April 13, 2026 — American Fusion (OTC: AMFN) a developer of next-generation fusion energy technologies, reported its participation in the 2026 ARPA-E Energy Innovation Summit, where the company advanced its commercialization strategy, strengthened relationships with government agencies, research institutions and industry participants, and refined its positioning within the evolving fusion landscape. The company highlighted progress on its Texatron(TM) roadmap, identified data centers as a key initial customer segment for high-density power solutions, evaluated supply chain partnerships for critical inputs such as helium-3 and deuterium, and explored potential capital markets expansion, including a Frankfurt listing, as it moves toward scalable deployment of its modular fusion technologies.
April 13, 2026 — Disseminated on behalf of MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF)and may include paid advertising.
April 13, 2026 — This article has been disseminated on behalf of MindBio Therapeutics Corp. and may include paid advertising.
April 13, 2026 — This article has been disseminated on behalf of Nicola Mining Inc. and may include paid advertising.
April 13, 2026 — Oragenics (NYSE American: OGEN), a clinical-stage biotechnology company focused on brain-targeted therapeutics, announced that the first patient has been dosed in its Phase IIa clinical trial evaluating ONP-002 for concussion and mild traumatic brain injury at Mackay Hospital in Australia, shortly after site activation on March 31, 2026. The milestone follows regulatory approval and highlights progress in advancing a first-in-class intranasal neurosteroid designed to address underlying brain injury mechanisms, as the company expands trial sites and targets a large unmet need in a condition with no FDA-approved pharmacological treatments.
April 13, 2026 — Safe Pro Group (NASDAQ: SPAI), a developer of AI-enabled defense, security and situational awareness solutions, announced the commercial rollout of its NODE-X, a next-generation, miniaturized AI-powered edge compute processor designed to analyze drone footage for real-time threat detection in military missions, following a recent government contract award. The backpack-deployable system leverages the company’s patented SPOTD technology trained on millions of real-world images to detect threats such as landmines, UXO and drones, while generating 3D mapping and route guidance without connectivity, and is scheduled for additional U.
April 13, 2026 — NRx Pharmaceuticals (NASDAQ: NRXP), a biopharmaceutical company focused on neuroplastic therapies for depression, PTSD and related conditions, announced the appointment of Glenn Tyson as its first Chief Commercial Officer as the company prepares for anticipated approval of its Abbreviated New Drug Application for a preservative-free ketamine product. Tyson brings more than 25 years of commercialization and sales experience, including senior leadership roles at GSK and Indivior, where he led the successful launch of SUBLOCADE(R), and will oversee the buildout of market access, distribution, sales and marketing capabilities to support upcoming product launches and the company’s broader psychiatry pipeline, including NRX-100 and NRX-101.
April 13, 2026 — This article has been disseminated on behalf of Nevada Organic Phosphate Inc. and may include paid advertising.